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Edited by Richard CogdellAbstract In the malaria parasite Plasmodium falciparum iso-
prenoid precursors are synthesised inside a plastid-like organelle
(apicoplast) by the mevalonate independent 1-deoxy-D-xylulose-
5-phosphate (DOXP) pathway. The last reaction step of the
DOXP pathway is catalysed by the LytB enzyme which contains
a [4Fe–4S] cluster. In this study, LytB of P. falciparum was
shown to be catalytically active in the presence of an NADPH
dependent electron transfer system comprising ferredoxin and
ferredoxin-NADP+ reductase. LytB and ferredoxin were found
to form a stable protein complex. These data suggest that the
ferredoxin/ferredoxin-NADP+ reductase redox system serves
as the physiological electron donor for LytB in the apicoplast
of P. falciparum.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Similarly to most other parasitic protozoa of the phylum
Apicomplexa, the malaria parasite Plasmodium falciparum
possesses a characteristic non-photosynthetic plastid-like orga-
nelle, the so-called apicoplast [1]. It is now widely accepted that
this organelle is derived from an algal endosymbiont engulfed
by an ancestor of the extant Apicomplexa. The apicoplast is
surrounded by four membranes, as it is the case for the plastids
of some unicellular algae such as cryptophytes and dinoﬂagel-
lates. The residual 35 kb circular apicoplast genome contains
mostly genes related to organellar replication, transcription
and translation, while the large majority of apicoplast-Abbreviations: DMAPP, dimethylallyl diphosphate; DOXP, 1-deoxy-
D-xylulose-5-phosphate; Fd, ferredoxin; FNR, ferredoxin-NADP+
reductase; HMBPP, (E)-4-hydroxy-3-methyl-but-2-enyl diphosphate;
IPP, isopentenyl diphosphate
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doi:10.1016/j.febslet.2005.10.037localised proteins is nuclear-encoded and transported into
the organelle. The metabolic functions of the apicoplast were
unknown until quite recently. It is now known that the early
steps of isoprenoid biosynthesis, in addition to fatty acid syn-
thesis and parts of the haem synthesis, occur inside the apicop-
last [2]. In contrast to animals, fungi and archaebacteria, which
use the classical mevalonate pathway for isoprenoid synthesis,
in P. falciparum isoprenoids are synthesised via the 1-deoxy-
D-xylulose 5-phosphate (DOXP) pathway [3–5]. This pathway
(also called the 2-C-methyl-D-erythritol-4-phosphate (MEP)
pathway) is present in most eubacteria and was discovered
only quite recently [6]. In higher plants both pathways are
present: the mevalonate pathway is operative in the cytosol
and the DOXP pathway in the plastids. In P. falciparum only
the apicoplast-localised DOXP pathway is present while there
is no evidence for the existence of a cytosolic mevalonate path-
way, as in some algae, which also lack the cytosolic mevalo-
nate pathway [7].
The DOXP pathway of P. falciparum has attracted con-
siderable interest as a target for new antimalarial drugs
[8–10]. Fosmidomycin, a natural antibiotic originally isolated
from Streptomyces lavendulae, was found to inhibit DOXP
reductoisomerase, the second enzyme of the reaction cascade
[11,12]. In recent clinical trials the antimalarial eﬃcacy of
fosmidomycin was evaluated in patients suﬀering from acute
uncomplicated P. falciparum infections. The treatment with
fosmidomycin was very well tolerated and eﬃcient in initial
parasite and fever clearance [13]. However, parasites re-ap-
peared in several patients after termination of the treatment.
Thus, fosmidomycin was further tested in combination with
clindamycin [14]. Clindamycin is supposed to inhibit the
prokaryote-type translation machinery of the apicoplast.
The fosmidomycin–clindamycin combination was highly
eﬃcient with a three-day regimen resulting in an overall cure
rate of approximately 95%. Based on the proven clinical
eﬃcacy of fosmidomycin the characterisation of additional
P. falciparum derived enzymes of the DOXP pathway is
highly desirable. These enzymes could ﬁnally serve as targets
for other new antimalarial drugs, which may be used in
combination with fosmidomycin. Such a combination able
to shut down the DOXP pathway at two diﬀerent steps is
expected to result in a pronounced synergistic increase in
eﬃcacy.blished by Elsevier B.V. All rights reserved.
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isation of the P. falciparum LytB enzyme [(E)-4-hydroxy-3-
methyl-but-2-enyl diphosphate (HMBPP) reductase, IspH]
together with its physiological electron shuttle system was
achieved. LytB catalyses the last step of the DOXP pathway
which consists in the simultaneous production of isopentenyl
diphosphate (IPP) and dimethylallyl diphosphate (DMAPP)
from HMBPP (Fig. 1). Previously it was shown that LytB,
similar to GcpE which catalyses the formation of HMBPP
from 2-C-methyl-D-erythritol-2,4-cyclodiphosphate, contains
an oxygen-labile [4Fe–4S] cluster predicted to be involved
in the transfer of two single electrons to the substrate [15–
17]. In experiments with LytB of the thermophilic bacterium
Aquifex aeolicus dithionite or reduced methyl viologen could
be used as artiﬁcial electron donor in order to demonstrate
the enzymatic activity in vitro [15]. In two other studies it
was demonstrated that LytB of Escherichia coli is catalyti-
cally active in the presence of ﬂavodoxin, ﬂavodoxin reduc-
tase and NADPH [18,19]. A slightly lower activity was
observed with photoreduced 5-deazaﬂavine [18]. Similarly,
it was shown that GcpE of E. coli productively interacts
with ﬂavodoxin/ﬂavodoxin reductase [16]. These data suggest
that probably in most bacteria ﬂavodoxin serves as the nat-
ural electron donor for both GcpE and LytB. Indeed, it was
shown very recently that providing electrons to GcpE, and
most likely also to LytB, is obviously the most important
function of ﬂavodoxin I in E. coli [20]. However, ﬂavodoxin
is not present in the plant plastids and the plastid-like orga-
nelle of the Apicomplexa, and so far there have been no re-
ports on the nature of the corresponding electron shuttle
systems interacting with GcpE or LytB in any of these
organisms. Recombinant GcpE of the higher plant Arabid-
opsis thaliana was active with photoreduced 5-deazaﬂavin,
but there was no activity with ﬂavodoxin/ﬂavodoxin reduc-
tase [21]. A recent study demonstrated that in Thermosyn-
echococcus elongatus BP-1, a thermophilic cyanobacterium
also lacking ﬂavodoxin, the electron transfer from ferredoxin
(Fd) to GcpE seems possible [22]. It also was reported that
LytB of E. coli possesses some, albeit very low, activity with
Fd and ferredoxin-NADP+-reductase (FNR) from spinach
[19]. In the present study, it was investigated whether LytB
of P. falciparum is able to interact with the apicoplast-
localised plant-type Fd/FNR system that had been











pyruvate + glyceraldehyde 3-phosphate
Fig. 1. Reaction catalysed by LytB. HMBPP, which is formed in several st
converted into IPP and DMAPP. IPP and DMAPP represent the universal2. Materials and methods
2.1. Work under oxygen exclusion
All work requiring anaerobic conditions was carried out in a tent
(Coy Laboratory Products, Inc., Grass Lake, USA) ﬂoated with a
gas mixture consisting of 95% N2 and 5% H2. Residual O2 was re-
moved with palladium catalysts. Buﬀers were degassed in an ultra-
sound bath by bubbling a stream of helium through the liquid.
Before use, the buﬀers were equilibrated overnight in the tent under
stirring. For the enzyme activity assays a spectrophotometer (DU
530 with a Peltier temperature control module, Beckman Coulter)
was installed inside the tent.2.2. Gene synthesis and plasmid construction
Due to the high A/T content of the P. falciparum genome fully syn-
thetic genes adapted to the preferred codon usage of E. coli were used
for the recombinant production of LytB and ferredoxin. The synthetic
genes were designed to encode only the mature part of the proteins
generated after cleavage of the presumed apicoplast targeting se-
quence. Based on multiple sequence alignments the ﬁrst amino acid
of the recombinant LytB protein was deﬁned by Pro218 of the deduced
pre-processed protein (GenBank accession number CAD49005). The
recombinant Fd started with Phe98 of the pre-processed form [24].
The desired genes were divided into a series of overlapping oligonucle-
otides which were assembled by PCR (Supplementary material). The
resulting product was cloned into the pCR2.1 TOPO vector (Invitro-
gen) and veriﬁed by double stranded sequencing. Both synthetic genes
were sub-cloned into the tetracycline inducible vector pASK-IBA33-
plus (IBA GmbH, Go¨ttingen, Germany) using two oppositely directed
Bsa I restriction sites. The lytB gene was cloned in-frame with the vec-
tor-derived sequence encoding a C-terminal His6 aﬃnity tag. Recombi-
nant ferredoxin was produced without an aﬃnity tag by placing a stop
codon at the end of the synthetic gene. The two constructs were re-
ferred to as pPfLytB and pPfFd, respectively. The coding sequence
of the putative mature P. falciparum FNR, starting from Lys56 of
the precursor protein (PlasmoDB accession code PFF1115w), was
initially isolated by PCR from genomic DNA under the condition
previously described [24] using the primers 5 0-GGCCAATTGAAAG-
AAGAAAACAATTTTATAAAT-3 0 and 5 0-GCGCAATTGTTAG-
TACACCTCAACGTGCACCCT-30 and cloned into pCR2.1-TOPO
(Invitrogen). The insert of the resulting plasmid was engineered to
place a sequence encoding the protease factor Xa recognition site in
front of the ﬁrst FNR codon and recloned in pET28b (Novagen) in
frame with the sequence encoding an N-terminal His6 aﬃnity tag to
yield the expression plasmid pET-PfFNR.2.3. Puriﬁcation of recombinant proteins
For the recombinant production of P. falciparum LytB and Fd,
E. coli TOP10 cells (Invitrogen) were transformed with pPfLytB and
pPfFd, respectively, and grown in Standard I medium (Merck) supple-
mented with 300 lM FeCl3. Induction was achieved with 0.2 mg l
1
anhydrotetracycline. LytB was puriﬁed under anaerobic conditions

















eps from pyruvate and glyceraldehyde 3-phosphate, is simultaneously
precursors of all isoprenoids.
R.C. Ro¨hrich et al. / FEBS Letters 579 (2005) 6433–6438 6435LON Superﬂow, BD Clontech) eluted with an imidazole step gradient
followed by strong cation exchange chromatography (Source 15 S,
Amersham). Fd was puriﬁed by weak and strong anion exchange chro-
matography using a DEAE Sepharose (Sigma–Aldrich) and a Source
15 Q (Amersham) column. P. falciparum FNR was overproduced in
the E. coli strain Rosetta(DE3) (Novagen) transformed with pET-
PfFNR. The cells were grown in 2· YT medium and the expression in-
duced with 0.1 mM IPTG. The recombinant enzyme was puriﬁed by
nickel chelate chromatography (Ni Sepharose, Amersham) and the
His6 tag removed by treatment with factor Xa (Pierce). The ﬁnal puri-
ﬁcation of the enzyme was achieved by a second passage through the
same column, exploiting the slight intrinsic aﬃnity of the native pro-
tein for the nickel ion.2.4. LytB activity assay with methyl viologen
The LytB activity was determined by monitoring the oxidation of
dithionite-reduced methyl viologen at 732 nm (e732 = 2200 M
1 cm1).
The assay mixture consisted of 30 mM Tris–HCl (pH 7.5), 2 mM
methyl viologen, 1.5 lM LytB and varying concentrations of HMBPP
in a total volume of 1.6 ml. The methyl viologen was partly reduced by
the addition of sodium dithionite until an extinction between 1.3 and
1.4 at 732 nm was reached, corresponding to 0.59–0.64 mM reduced
methyl viologen. Typically, 10 ll of a 100 mM sodium dithionite stock
solution were added to the reaction mixture. The solid sodium dithio-
nite was stored in the oxygen-free tent and the stock solution freshly
prepared under anaerobic conditions. HMBPP used as substrate was
obtained by chemical synthesis [26].2.5. LytB activity assay with ferredoxin/ferredoxin-NADP+ reductase
For determination of the LytB activity in the presence of Fd and
FNR the consumption of NADPH was monitored in a spectropho-
tometer. The assay mixture contained 150 mM NaCl, 30 mM Tris–
HCl (pH 7.5), 2 mM DTT, 1 mM HMBPP, 0.5 mM NADPH, 4 lM
Fd, 1 lM FNR, and 7 nM LytB in a total volume of 1.6 ml. The mix-
ture was incubated at 30 C and the NADPH turnover monitored at
365 nm (e365 = 3500 M
1 cm1).2.6. Detection of reaction products by high-performance liquid
chromatography–electrospray ionisation–mass spectrometry
(HPLC–ESI–MS)
In order to achieve a quantitative conversion of the substrates a
reaction mixture containing 150 mM NaCl, 30 mM Tris–HCl (pH
7.5), 2 mM DTT, 1 mM HMBPP, 1 mM NADPH, 7.5 lM Fd,
0.5 lM FNR, and 1.5 lM LytB in a total volume of 1.6 ml was pre-
pared and the absorption monitored at 380 nm until completion of
the reaction. The reaction product was then analysed by HPLC–
ESI–MS using a Micromass ZQ 4000 (Waters, Milford, MA). Chro-
matography was performed on a 2 · 250 mm Ion Pack AS11-HC
column (Dionex Corporation, Sunnyvale, CA) with a 2 · 50 mm guard
column. A binary gradient was applied by a Waters Separation Mod-
ule 2795. Eluent A was 20 mM NH4HCO3 in water, 10% methanol
(v/v); eluent B was 0.6 M NH4HCO3 in water, 10% methanol (v/v). The
injection volume was 20 ll, the ﬂow rate was 250 ll min1 directly into
the mass spectrometer. The gradient applied for separation was: 5 min
50% B; linear increase to 100% B in 30 min; 15 min 50% B. Mass peaks
were detected by single ion recording in negative mode [M  H] for
HMBPP (m/z 261), IPP (m/z 245) and DMAPP (m/z 245) with the fol-
lowing settings: desolvation temperature 250 C; source temperature
120 C; capillary voltage 3.0 kV; cone voltage 20 V; extractor voltage
3 V; RF lens voltage 0.5 V.Fig. 2. Sodium dodecyl sulfate–polyacrylamide gel electrophoresis
(SDS–PAGE) analysis of the recombinant LytB (lane 1), Fd (lane 2)
and FNR (lane 3) of P. falciparum. 1 lg of protein was loaded on each
lane. Molecular mass standards are indicated in kDa.2.7. Analytical size exclusion chromatography
Complex formation of LytB with Fd was monitored by analytical
size exclusion chromatography (SEC). LytB and Fd were combined
at a ﬁnal concentration of each 50 lM in 20 mM Na phosphate buﬀer
(pH 7.5) containing 150 or 400 mM NaCl. After incubation for 10 min
at room temperature 100 ll of the mixture were loaded onto a
1 · 30 cm Superdex 75 column (Amersham) equilibrated with 20 mM
Na phosphate buﬀer (pH 7.5) containing the appropriate NaCl con-
centration. The column was run at 0.4 ml min1 using a Waters 2795
HPLC device equipped with a diode array detector. N-hydroxy-
succinimide was added to the sample as an internal standard in orderto monitor the uniformity of diﬀerent runs. The column was calibrated
with ribonuclease A (14 kDa), chymotrypsinogen A (25 kDa), car-
bonic anhydrase (29 kDa), ovalbumin (43 kDa), bovine serum albumin
(67 kDa) and thyroglobulin (669 kDa).3. Results and discussion
3.1. Recombinant production and puriﬁcation of LytB,
ferredoxin and ferredoxin-NADP+ reductase of
P. falciparum
Fully synthetic genes optimised for the codon usage of
E. coli were used for the recombinant production of P. falcipa-
rum LytB and ferredoxin. The His6-tagged LytB was puriﬁed
by immobilised metal aﬃnity and cation exchange chromatog-
raphy (Fig. 2). The untagged ferredoxin was puriﬁed using a
weak and a strong anion exchanger. Notwithstanding the high
A/T content of its coding sequence, a good synthesis of P. fal-
ciparum FNR was obtained in E. coli with pET-PfFNR using
as host the Rosetta(DE3) strain, which was speciﬁcally engi-
neered to enhance the expression of eukaryotic proteins con-
taining codons rarely used in E. coli. To facilitate its
puriﬁcation, the enzyme was produced with an N-terminal
His6 tag, which was removed by proteolysis during the puriﬁ-
cation. The LytB protein was rapidly inactivated after expo-
sure to oxygen, while there was no evidence for oxygen
sensitivity of Fd and FNR (not shown).
3.2. Enzymatic characterisation of P. falciparum LytB with
methyl viologen as artiﬁcial electron donor
Initial enzymatic characterisation of the P. falciparum LytB
was done with reduced methyl viologen as an artiﬁcial electron
donor. The change of colour from blue to colourless during the
oxidation of the methyl viologen was monitored at 732 nm.
Using this assay the temperature dependency of the P. falcipa-
rum LytB activity was determined over a range from 15 to
50 C (Supplementary material). There was a continuous
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could be obtained with the available equipment). An activation
energy of approximately 8.0 kJ mol1 was estimated based on
the Arrhenius plot. All subsequent activity tests were done at
30 C. For the determination of the kinetic parameters, the
LytB activity was measured with diﬀerent HMBPP concentra-
tions ranging from 0.02 to 3 mM (Supplementary material).
Based on Michaelis–Menten and Lineweaver–Burk plots, the
Km value for HMBPP was calculated to be approximately
39 lM. Maximal speciﬁc activity was approximately
2.1 l mol min1 mg1, corresponding to a kcat value of
approx. 1.3 s1.
3.3. Enzymatic characterisation of P. falciparum LytB with
ferredoxin/ferredoxin-NADP+ reductase as electron donor
When the P. falciparum LytB was incubated with the P. fal-
ciparum Fd and P. falciparum FNR in the presence of HMBPP
and NADPH a continuous decrease of the NADPH speciﬁc
absorption at 365 nm was observed (Fig. 3A). No such
NADPH oxidation was observed when one of the assay com-
ponents was omitted, suggesting a speciﬁc electron ﬂow from
NADPH via FNR and Fd to LytB. For maximal speciﬁc LytB
activity a considerable excess of Fd (4 lM) and FNR (1 lM)
compared to LytB (7 nM) had to be used. Under these condi-




































Fig. 3. Activity of the P. falciparum LytB with Fd/FNR. (A)
Monitoring of the NADPH speciﬁc absorption at 365 nm in the assay
mixture containing all substrates (decrease of absorption) and a
control without HMBPP (no change of absorption). (B) Comparison
of the P. falciparum (PfLytB) and A. aeolicus (AaLytB) LytB activity
with methyl viologen (MV) or the P. falciparum Fd/FNR system. The
P. falciparum LytB concentration was 7 nM for the assay with Fd/
FNR; in the other assays the LytB concentration was 70 nM in order
to achieve a quantiﬁable slope of the absorption.icantly higher than that observed in the methyl viologen assay
(Fig. 3B). In contrast, only marginal activity was observed
when the P. falciparum LytB was replaced by LytB of the bac-
terium A. aeolicus (Fig. 3B).
The reaction products obtained with the P. falciparum LytB
in the presence of Fd/FNR were analysed by HPLC–ESI–MS.
The assay mixture was separated on an anion exchange col-
umn and mass tracks recorded for HMBPP, IPP and DMAPP.
Using equimolar amounts of HMBPP and NADPH in the
reaction mixture, HMBPP was quantitatively converted into
IPP and DMAPP (Fig. 4). The ratio of IPP and DMAPP
was between 5:1 and 4:1 similar to the results reported for
LytB of A. aeolicus and E. coli [15,18,19]. A comparable result
was obtained in an experiment with LytB of A. aeolicus and
Fd/FNR of P. falciparum, albeit the conversion rate was much
lower (Fig. 4).
3.4. Complex formation of P. falciparum LytB with ferredoxin
The P. falciparum LytB was further investigated by evaluat-
ing its ability to form a stable complex with Fd. Thus, LytB andFig. 4. Detection of the substrate and products of the LytB catalysed
reaction by HPLC–ESI–MS. The samples were separated on an anion
exchange column, and mass chromatograms recorded for HMBPP
(m/z 261), IPP (m/z 245) and DMAPP (m/z 245). (A) Mixture of
standard compounds (1 mM HMBPP, 0.5 mM IPP, and 0.5 mM
DMAPP). (B) Reaction mixture before the addition of LytB. (C)
Reaction product obtained with P. falciparum LytB and P. falciparum
Fd/FNR. (D) Reaction product obtained with A. aeolicus LytB and P.
falciparum Fd/FNR. The chromatogram in panel D was ampliﬁed 10-
fold. The asterisk indicates the Z-isomer of HMBPP which was present
as an impurity of the HMBPP sample.
Fig. 5. Detection of the formation of a LytB-ferredoxin complex by
size exclusion chromatography. P. falciparum LytB (PfLytB) and A.
aeolicus LytB (AaLytB), respectively, were mixed with P. falciparum Fd
(PfFd) in the presence of the indicated salt concentrations and analysed
on a Superdex 75 column. The elution of the column was monitored at
280 nm. N-hydroxysuccinimide was used as internal standard. The
individual peak fractions deﬁned by numbers 1–7 were analysed by
SDS–PAGE (insets). UV–visible spectra were recorded of the fractions
obtained with the P. falciparum LytB and Fd in the presence of 150 mM
NaCl. The spectra were normalised to the absorption at 277 nm.
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The elution of the column was monitored by a diode array
detector allowing the identiﬁcation of the two protein species
by their speciﬁc UV–visible spectra. When the P. falciparum
LytB and Fd were chromatographed separately, their retention
times were 27 and 31 min, respectively (not shown). The corre-
sponding molecular masses estimated from the calibration
curve were 32 and 19 kDa which is in accordance with the the-
oretical values of 37.4 and 11.4 kDa with respect to the limited
resolution of the method. When the mixture of both proteins
was analysed, an additional peak appeared at 26 min corre-
sponding to an apparent molecular mass of 39 kDa (Fig. 5).
The absorption spectra showed that this new peak is likely to
represent a complex of LytB and Fd (Fig. 5). This result was
further conﬁrmed by SDS–PAGE analysis of the diﬀerent frac-
tions (Fig. 5). The remarkably diﬀerent isoelectric points (pI) of
the P. falciparum LytB and Fd (calculated pI values 9.0 and 4.4,
respectively) suggest that the interaction is mainly of electro-
static nature. Therefore, the salt concentration in the experi-
ment was increased from 150 to 400 mM. As expected, no
complex formation of the two proteins was observed under
these conditions (Fig. 5). The same experiment with 150 mM
salt was repeated with the A. aeolicus LytB and P. falciparum
Fd. It was found that the A. aeolicus LytB, which behaves as
a homodimer in the size exclusion chromatography, did not
associate with the P. falciparum Fd (Fig. 5).4. Conclusions
These results demonstrate that in P. falciparum the Fd/
FNR redox system can serve as an electron donor for LytB,
which catalyses the last step of the apicoplast localised
DOXP pathway of isoprenoid biosynthesis. This is the ﬁrst
experimental evidence for Fd/FNR being directly involved
in a metabolic pathway of the apicoplast. Whether also
the GcpE enzyme of P. falciparum depends on Fd/FNR re-
mains to be shown. It can be suggested that also in plant
plastids Fd/FNR acts as electron donor for LytB and,
potentially, GcpE.
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